Qu Biologics and TransBIOTech Awarded $450K Applied Research and Development Grant Funding
BURNABY, BC – Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to announce, in partnership… Read More




